Breaking News, Collaborations & Alliances

RiboBio, GE Healthcare Partner for Oligonucleotide Drug Development

The goal of the strategic agreement is a total solution for oligonucleotide drug companies worldwide

RiboBio Co., Ltd. and GE Healthcare Life Sciences held a strategic partnership signing ceremony at the 5th Canton Nucleic Acids Forum in Guangzhou, China.    Dr. Biliang  Zhang, president of RiboBio, and Mrs. Shufang Lim, chief commercial director of GE Healthcare Life Science China, executed the strategic partnership. The agreement aims to jointly build Asia’s largest oligonucleotide drug development and manufacturing facility, and also to provide a total solution for oligonucleot...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters